References
1. Ring, D. B., Johnson, K. W., Henriksen, E. J., Nuss, J. M., Goff, D., Kinnick, T. R., Wagman, A. S. (2003). Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes, 52(3), 588-595. 2. Naujok, O., Lentes, J., Diekmann, U., Davenport, C., Lenzen, S. (2014). Cytotoxicity and activation of the Wnt/beta-catenin pathway in mouse embryonic stem cells treated with four GSK3 inhibitors. BMC research notes, 7(1), 1. 3. Lian, X., Bao, X., Al-Ahmad, A., Liu, J., Wu, Y., Dong, W., Palecek, S. P. (2014). Efficient differentiation of human pluripotent stem cells to endothelial progenitors via small-molecule activation of WNT signaling.Stem cell reports, 3(5), 804-816. 4. Lian, X., Hsiao, C., Wilson, G., Zhu, K., Hazeltine, L. B., Azarin, S. M., Palecek, S. P. (2012). Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proceedings of the National Academy of Sciences, 109(27), E1848-E1857.USBio References
No references available
TDS
NCBI
UniProt
Tech Support
Customer Service
